2024-09-09 2025-09-30 2025-09-30 false 15943996 THE THERAPY SPACE CLINIC LTD 2026-08-20 82990 false iso4217:GBP xbrli:pure 15943996 2024-09-08 15943996 2025-09-30 15943996 2024-09-09 2025-09-30 15943996 2024-09-07 15943996 2024-09-08 15943996 2024-09-08 2024-09-08 15943996 bus:SmallEntities 2024-09-09 2025-09-30 15943996 bus:AuditExempt-NoAccountantsReport 2024-09-09 2025-09-30 15943996 bus:FullAccounts 2024-09-09 2025-09-30 15943996 bus:PrivateLimitedCompanyLtd 2024-09-09 2025-09-30 15943996 core:WithinOneYear 2025-09-30 15943996 core:AfterOneYear 2025-09-30 15943996 core:WithinOneYear 2024-09-08 15943996 core:AfterOneYear 2024-09-08 15943996 core:ShareCapital 2025-09-30 15943996 core:SharePremium 2025-09-30 15943996 core:RevaluationReserve 2025-09-30 15943996 core:OtherReservesSubtotal 2025-09-30 15943996 core:RetainedEarningsAccumulatedLosses 2025-09-30 15943996 core:ShareCapital 2024-09-08 15943996 core:SharePremium 2024-09-08 15943996 core:RevaluationReserve 2024-09-08 15943996 core:OtherReservesSubtotal 2024-09-08 15943996 core:RetainedEarningsAccumulatedLosses 2024-09-08 15943996 core:LandBuildings 2025-09-30 15943996 core:PlantMachinery 2025-09-30 15943996 core:Vehicles 2025-09-30 15943996 core:FurnitureFittings 2025-09-30 15943996 core:OfficeEquipment 2025-09-30 15943996 core:NetGoodwill 2025-09-30 15943996 core:IntangibleAssetsOtherThanGoodwill 2025-09-30 15943996 core:ListedExchangeTraded 2025-09-30 15943996 core:UnlistedNon-exchangeTraded 2025-09-30 15943996 core:LandBuildings 2024-09-08 15943996 core:PlantMachinery 2024-09-08 15943996 core:Vehicles 2024-09-08 15943996 core:FurnitureFittings 2024-09-08 15943996 core:OfficeEquipment 2024-09-08 15943996 core:NetGoodwill 2024-09-08 15943996 core:IntangibleAssetsOtherThanGoodwill 2024-09-08 15943996 core:ListedExchangeTraded 2024-09-08 15943996 core:UnlistedNon-exchangeTraded 2024-09-08 15943996 core:LandBuildings 2024-09-09 2025-09-30 15943996 core:PlantMachinery 2024-09-09 2025-09-30 15943996 core:Vehicles 2024-09-09 2025-09-30 15943996 core:FurnitureFittings 2024-09-09 2025-09-30 15943996 core:OfficeEquipment 2024-09-09 2025-09-30 15943996 core:NetGoodwill 2024-09-09 2025-09-30 15943996 core:IntangibleAssetsOtherThanGoodwill 2024-09-09 2025-09-30 15943996 core:ListedExchangeTraded 2024-09-09 2025-09-30 15943996 core:UnlistedNon-exchangeTraded 2024-09-09 2025-09-30 15943996 core:MoreThanFiveYears 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments 2025-09-30 15943996 core:Non-currentFinancialInstruments 2024-09-08 15943996 dpl:CostSales 2024-09-09 2025-09-30 15943996 dpl:DistributionCosts 2024-09-09 2025-09-30 15943996 core:LandBuildings 2024-09-09 2025-09-30 15943996 core:PlantMachinery 2024-09-09 2025-09-30 15943996 core:Vehicles 2024-09-09 2025-09-30 15943996 core:FurnitureFittings 2024-09-09 2025-09-30 15943996 core:OfficeEquipment 2024-09-09 2025-09-30 15943996 dpl:AdministrativeExpenses 2024-09-09 2025-09-30 15943996 core:NetGoodwill 2024-09-09 2025-09-30 15943996 core:IntangibleAssetsOtherThanGoodwill 2024-09-09 2025-09-30 15943996 dpl:GroupUndertakings 2024-09-09 2025-09-30 15943996 dpl:ParticipatingInterests 2024-09-09 2025-09-30 15943996 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-09 2025-09-30 15943996 core:ListedExchangeTraded 2024-09-09 2025-09-30 15943996 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-09 2025-09-30 15943996 core:UnlistedNon-exchangeTraded 2024-09-09 2025-09-30 15943996 dpl:CostSales 2024-09-08 2024-09-08 15943996 dpl:DistributionCosts 2024-09-08 2024-09-08 15943996 core:LandBuildings 2024-09-08 2024-09-08 15943996 core:PlantMachinery 2024-09-08 2024-09-08 15943996 core:Vehicles 2024-09-08 2024-09-08 15943996 core:FurnitureFittings 2024-09-08 2024-09-08 15943996 core:OfficeEquipment 2024-09-08 2024-09-08 15943996 dpl:AdministrativeExpenses 2024-09-08 2024-09-08 15943996 core:NetGoodwill 2024-09-08 2024-09-08 15943996 core:IntangibleAssetsOtherThanGoodwill 2024-09-08 2024-09-08 15943996 dpl:GroupUndertakings 2024-09-08 2024-09-08 15943996 dpl:ParticipatingInterests 2024-09-08 2024-09-08 15943996 dpl:GroupUndertakings core:ListedExchangeTraded 2024-09-08 2024-09-08 15943996 core:ListedExchangeTraded 2024-09-08 2024-09-08 15943996 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-09-08 2024-09-08 15943996 core:UnlistedNon-exchangeTraded 2024-09-08 2024-09-08 15943996 core:NetGoodwill 2025-09-30 15943996 core:IntangibleAssetsOtherThanGoodwill 2025-09-30 15943996 core:LandBuildings 2025-09-30 15943996 core:PlantMachinery 2025-09-30 15943996 core:Vehicles 2025-09-30 15943996 core:FurnitureFittings 2025-09-30 15943996 core:OfficeEquipment 2025-09-30 15943996 core:AfterOneYear 2025-09-30 15943996 core:WithinOneYear 2025-09-30 15943996 core:ListedExchangeTraded 2025-09-30 15943996 core:UnlistedNon-exchangeTraded 2025-09-30 15943996 core:ShareCapital 2025-09-30 15943996 core:SharePremium 2025-09-30 15943996 core:RevaluationReserve 2025-09-30 15943996 core:OtherReservesSubtotal 2025-09-30 15943996 core:RetainedEarningsAccumulatedLosses 2025-09-30 15943996 core:NetGoodwill 2024-09-08 15943996 core:IntangibleAssetsOtherThanGoodwill 2024-09-08 15943996 core:LandBuildings 2024-09-08 15943996 core:PlantMachinery 2024-09-08 15943996 core:Vehicles 2024-09-08 15943996 core:FurnitureFittings 2024-09-08 15943996 core:OfficeEquipment 2024-09-08 15943996 core:AfterOneYear 2024-09-08 15943996 core:WithinOneYear 2024-09-08 15943996 core:ListedExchangeTraded 2024-09-08 15943996 core:UnlistedNon-exchangeTraded 2024-09-08 15943996 core:ShareCapital 2024-09-08 15943996 core:SharePremium 2024-09-08 15943996 core:RevaluationReserve 2024-09-08 15943996 core:OtherReservesSubtotal 2024-09-08 15943996 core:RetainedEarningsAccumulatedLosses 2024-09-08 15943996 core:NetGoodwill 2024-09-07 15943996 core:IntangibleAssetsOtherThanGoodwill 2024-09-07 15943996 core:LandBuildings 2024-09-07 15943996 core:PlantMachinery 2024-09-07 15943996 core:Vehicles 2024-09-07 15943996 core:FurnitureFittings 2024-09-07 15943996 core:OfficeEquipment 2024-09-07 15943996 core:AfterOneYear 2024-09-07 15943996 core:WithinOneYear 2024-09-07 15943996 core:ListedExchangeTraded 2024-09-07 15943996 core:UnlistedNon-exchangeTraded 2024-09-07 15943996 core:ShareCapital 2024-09-07 15943996 core:SharePremium 2024-09-07 15943996 core:RevaluationReserve 2024-09-07 15943996 core:OtherReservesSubtotal 2024-09-07 15943996 core:RetainedEarningsAccumulatedLosses 2024-09-07 15943996 core:AfterOneYear 2024-09-09 2025-09-30 15943996 core:WithinOneYear 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:CostValuation 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-09 2025-09-30 15943996 core:Non-currentFinancialInstruments core:CostValuation 2025-09-30 15943996 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-09-30 15943996 core:Non-currentFinancialInstruments core:CostValuation 2024-09-08 15943996 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-09-08 15943996 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-09-08 15943996 bus:Director1 2024-09-09 2025-09-30

THE THERAPY SPACE CLINIC LTD

Registered Number
15943996
(England and Wales)

Unaudited Financial Statements for the Period ended
30 September 2025

THE THERAPY SPACE CLINIC LTD
Company Information
for the period from 9 September 2024 to 30 September 2025

Director | LOPEZ, Sharnelle

Registered Address | Forma House
| 40 Bowling Green Lane
| London
| EC1R 0NE

Registered Number | 15943996 (England and Wales)

THE THERAPY SPACE CLINIC LTD
Balance Sheet as at
30 September 2025

| Notes | 2025
--- | --- | ---
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 |  |  | 400
|  |  |  | 400
Current assets |  |  |  |
Cash at bank and on hand |  | 8,327 |  |
|  | 8,327 |  |
Creditors amounts falling due within one year | 4 | (3,215) |  |
Net current assets (liabilities) |  |  |  | 5,112
Total assets less current liabilities |  |  |  | 5,512
Net assets |  |  |  | 5,512
Capital and reserves |  |  |  |
Called up share capital |  |  |  | 1
Profit and loss account |  |  |  | 5,511
Shareholders' funds |  |  |  | 5,512

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 20 August 2026, and are signed on its behalf by:
LOPEZ, Sharnelle Director Registered Company No. 15943996

THE THERAPY SPACE CLINIC LTD
Notes to the Financial Statements
for the period ended 30 September 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

| Judgements and key sources of estimation uncertainty
--- | ---
| In preparing these financial statements, certain accounting records (including bank statements and expense documentation) were not available to the directors/accountant at the time of preparation. Where this was the case, the affected balances have been prepared using management's best estimates based on the information available. These estimates will be reviewed and adjusted, if necessary, once the underlying records are obtained.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Reducing balance (%)
| Office Equipment | 20

2. | Average number of employees
--- | ---

|  | 2025
| Average number of employees during the year | 0

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| Additions | 500 |  | 500
| At 30 September 25 | 500 |  | 500
| Depreciation and impairment
| Charge for year | 100 |  | 100
| At 30 September 25 | 100 |  | 100
| Net book value
| At 30 September 25 | 400 |  | 400
| At 08 September 24 | - |  | -

4. | Creditors: amounts due within one year
--- | ---

|  | 2025
--- | --- | ---
|  | £
| Bank borrowings and overdrafts | 1,536
| Taxation and social security | 1,199
| Accrued liabilities and deferred income | 480
| Total | 3,215